Avid Bioservices, Inc. (CDMO)
After hours:
| Previous Close | 30.56 |
| Open | 31.18 |
| Bid | 30.56 x 900 |
| Ask | 32.51 x 900 |
| Day's Range | 30.55 - 31.88 |
| 52 Week Range | 8.76 - 34.51 |
| Volume | |
| Avg. Volume | 959,982 |
| Market Cap | 1.874B |
| Beta (5Y Monthly) | 2.29 |
| PE Ratio (TTM) | 285.51 |
| EPS (TTM) | 0.11 |
| Earnings Date | Dec. 07, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 28.25 |
- GlobeNewswire
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2022 After Market Close on December 7, 2021
TUSTIN, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced that it will report financial results for the second quarter of fiscal year 2022 on December 7, 2021 after market close and will host a conference call and webcast at 1:30 PM Pacific Time (4:30 PM Eas
- Zacks
Avid Bioservices (CDMO) Earnings Expected to Grow: What to Know Ahead of Q2 Release
Avid Bioservices (CDMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GlobeNewswire
Avid Bioservices Appoints Elie G. Hanania, Ph.D., as Vice President, Process Development, Viral Vector Technologies
Seasoned Life Science Industry Executive with More Than 30 Years of Experience in Cell and Gene Therapy, Including Senior Level Viral Vector Development Positions with Fujifilm Diosynth Biotechnologies and Millipore SigmaTUSTIN, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechno
